This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Epilepsy in many patients remains poorly controlled despite the introduction of new antiepileptic drugs (AEDs).1 Neurostimulation, including vagus nerve stimulation (VNS), is a promising alternative to AEDs.2 The mechanism of VNS involves the locus ceruleus (LC) and nucleus solitarius (NTS).3,4⇓ As the LC and NTS project to the trigeminal nucleus, stimulation of the trigeminal nerve may also activate similar pathways to VNS.4-6⇓⇓ The trigeminal nerve, via cutaneous branches, offers a noninvasive method of neurostimulation. Recently, infraorbital trigeminal nerve stimulation (TNS) reduced pentylenetetrazol-induced seizures in rats.7 Given the potent antiepileptic effect in animals, we initiated a pilot study of infraorbital TNS for epilepsy.
Methods.
Research committee approval was obtained for a pilot study of TNS. Inclusion criteria were age of 18 to 65 years, four or more complex partial seizures (CPS) or secondarily generalized seizures per month, no significant cardiac or medical conditions, EEG demonstrating focal epileptic discharges, ability to maintain accurate seizure calendars, no trigeminal neuralgia, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy